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Dual Function of Drosophila Cells as APCs
for Naive CD81 T Cells:
Implications for Tumor Immunotherapy
Siquan Sun, Zeling Cai, as APCs and CD81 cells from the 2C line of T cell recep-
tor (TCR) transgenic mice (Sha et al., 1988) as responderPierre Langlade-Demoyen,* Hiroshi Kosaka,²
Anders Brunmark,³ Michael R. Jackson,³ cells. In this system, purified CD81 2C cells give strong
primary responses in vitro to peptides presented byPer A. Peterson,³ and Jonathan Sprent
Department of Immunology, IMM4 MHC class I (Ld)±transfected Drosophila cells, but only
when these cells coexpress both B7-1 and ICAM-1. InThe Scripps Research Institute
10666 North Torrey Pines Road the absence of these costimulatory molecules, the re-
sponse of CD81 cells is undetectable unless exogenousLa Jolla, California 92037
cytokines are added.
This paper demonstrates that the failure of 2C T cells
to give responses to peptides presented by DrosophilaSummary
cells expressing Ld molecules alone does not apply
when unseparated spleen cells are used as responders.With unseparated mouse spleen cells as responders,
In this situation, the CD81 cells in the spleen populationDrosophilacells expressing MHC class I (Ld) molecules
receive ªbystanderº costimulation from activated Balone lead to peptide-specific responses of CD81 cells
cells; B cell activation is induced by DNA released fromin the absence of exogenous cytokines. Under these
dying Drosophila cells. Utilizing this finding, we showconditions, DNA released from dying cells stimulates
that Ld-transfected Drosophila cells are able to inducethe B cells in spleen to up-regulate costimulatory mol-
normal DBA/2 spleencells to respond tosyngeneic P815ecules; these activated B cells then provide bystander
mastocytoma peptides in vitro in the absence of addedcostimulation for CD81 cells responding to class
lymphokines and generate effector cells capable ofI±peptide complexes on theDrosophila APCs. By stim-
leading to tumor rejection in vivo.ulating B cells and presenting antigen to T cells, Dro-
sophila cells thus serve two different functions in pro-
Resultsmoting primary responses of CD81 cells in vitro. With
this system, we show that Ld-transfected Drosophila
Experimental Systemcells are able to induce autologous spleen cells to
T cells in the 2C line of TCR transgenic mice undergorespond to a tumor-specific peptide in vitro and, after
positive selection to Kb and display strong alloreactivitytransfer, cause tumor rejection in vivo.
to Ld molecules plus either of two self-peptides, p2Ca
(8-mer) or QL9 (9-mer) (Sha et al., 1988, 1990; Cai andIntroduction
Sprent, 1994; Udaka et al., 1992; Sykulev et al., 1994b);
these peptides are derived from a Krebs cycle enzyme,The specificity of CD81 and CD41 T cells is directed
i.e., from a ubiquitous self-antigen. As discussed else-to peptides bound to major histocompatibility complex
where, the binding affinities involved in the interaction(MHC) class I and II molecules, respectively (Germain,
of p2Ca and QL9 peptides with Ld and 2C TCR molecules1993; Doherty et al., 1992; Janeway, 1992). For naive
are well defined (Sykulev et al., 1994a, 1994b; Corr etcells, T cell activation generally requires that peptide±
al., 1994). QL9 is the stronger peptide and has very highMHC complexes are displayed on the surface of viable
binding affinity for Ld (2 3 108 M21) and also for theantigen-presenting cells (APCs) such as dendritic cells.
2C TCR (2 3 107 M21 when complexed to Ld). In theThese ªprofessionalº APCs express a variety of costimu-
experiments discussed below, purified CD81 2C cellslatory molecules such as B7 (B7-1, B7-2), ICAM-1, and
or unseparated 2C spleen cells were cultured with QL9HSA (Schwartz, 1992; Azuma et al., 1993; Freeman et
peptide (prepared in synthetic form) and Drosophilaal., 1993; Janeway and Bottomly, 1994). Costimulation
cells transfected with the Ld gene linked to the metalla-is crucial for the activation of naive T cells and induces
thionein promoter; Ld expression was induced by prein-qualitatively distinct signals, which synergize with TCR-
cubating the cells with CuSO4. The level of Ld expressionmediated signals and induce cytokine production, T cell
on the cells was moderate and no higher than on normalproliferation, and differentiation into effector cells.
B10.D2 (Ld) spleen cells (Z. C. et al., submitted). For allAlthough the range of costimulatory molecules on
of the experiments discussed below, the cultures wereAPCs is considerable, we have recently established that
not supplemented with exogenous cytokines.expression of just two molecules, B7-1 and ICAM-1, is
sufficient for stimulating strong primary responses by
Response of 2C Spleen Cells to Ld APCsnaive CD81 cells (Z. C. et al., submitted). This conclusion
The complete inability of purified CD81 2C cells to re-is based on studies with transfected Drosophila cells
spond to QL9 peptide (10 mM) presented by Drosophila
cells expressing Ld alone (Ld APCs) is illustrated in Figure
*Current address: UniteÂ de Biologie Moleculaire du Gene, Institut 1B. By contrast, culturing unseparated 2C spleen cells
Pasteur, 25 rue du Dr. Roux, 75015 Paris, France. with QL9 peptide plus Ld APCs led to significant prolifer-²Current address: Walter and Eliza Hall Institute, Royal Melbourne
ative responses (Figures 1A and 1B). Except on day 2Hospital, Melbourne, Australia.
of culture (see below), responses of 2C spleen cells³Current address: R. W. Johnson Pharmaceutical Research, 3535
General Atomics Court, Suite 100, San Diego, California 92121. to Ld APCs were undetectable in the absence of QL9
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Figure 1. Response of 2C Spleen Cells to
QL9 Peptide Presented by Ld APCs; APCs
Were Used at 1 3 105 cells/well
(A) Proliferation of 2C spleen cells in vitro to
QL9 peptide (10 mM) presented by Drosophila
APCs expressing Ld, Db, or Kb class I mole-
cules.
(B, C, D) Proliferation of various doses of 2C
spleen cells to QL9 peptide (10 mM) pre-
sented by Ld APCs; in (B), the failure of puri-
fied 2C CD81 cells to respond to Ld APCs
plus QL9 peptide is shown.
(E, F) Dose of QL9 peptide required for prolif-
erative response of 2C spleen cells to Ld ver-
sus Ld.B7.ICAM APCs.
(G) IL-2 production in supernatants from cul-
ture of 2C spleen cells, Ld APCs, and QL9
peptide (10 mM); IL-2 production was mea-
sured by adding supernatants to the IL-2-
dependent CTLL line and then measuring
proliferation by addition of [3H]TdR (see Ex-
perimental Procedures).
(H) CTL activity of 2C spleen cells cultured
for 4 days with Ld APCs plus QL9 peptide (10
mM); CTL activity was tested on 51Cr-labeled
RMA-S.Ld cells sensitized with QL9 or LCMV
peptide or with no peptide (see Experimental
Procedures).
The data shown are the mean of triplicate
cultures; SD were generally within 10%±20%
of the mean. [3H]TdR incorporation refers
to cpm.
peptide, and no response occurred when QL9 peptide Culturing 2C spleen cells with Ld APCs plus QL9 pep-
tide for 4 days led to strong generation of cytotoxic Twas added to Drosophila cells expressing either Db or
Kb molecules. With high doses of 2C spleen cells (2±3 3 lymphocyte (CTL) activity with Ld-transfected RMA-S
(RMA-S.Ld) cells as targets (Figure 1H). CTL activity was105), the proliferative response reached a peak on day
3 (Figures 1A and 1B). At intermediate doses (1 3 105), peptide specific, since no lysis was seen in the absence
of QL9 peptide or when the target cells were sensitizedthe response occurred more slowly and peaked on day
4 or 5 (Figure 1C; data not shown); with low doses (3 3 with an irrelevant peptide, lymphocytic choriomeningitis
(LCMV) (Whitton et al., 1989).104), the response was undetectable (Figure 1D).
The response of 2C spleen cells to Ld APCs required
a high dose of QL9 peptide, i.e., 10 mM (1025 M) (Figures Drosophila Cells Cause B Cell Activation
To determine whether the proliferative response of 2C1E and 1F). This contrasted with Drosophila cells ex-
pressing Ld plus two costimulatory molecules, B7-1 and spleen cells to QL9 peptide plus Ld APCs was restricted
to T cells, the DNA precursor, bromodeoxyuridineICAM-1 (Ld.B7.ICAM APCs). With these strongly immu-
nogenic APCs, proliferative responses of 2C spleen cells (BrdU), was added to the cultures. After 2 days continu-
ous exposure to BrdU, the cells were harvested, stainedwere apparent with as low as 100 pM (10210 M) (Figures
1E and 1F). for surface expression of CD8 and B220, fixed, and then
stained for BrdU incorporation. As shown in Figure 2A,The proliferative response of 2C spleen cells to Ld
APCs plus a high dose of QL9 peptide (10 mM) was BrdU labeling of CD81 cells was high (67%) when 2C
spleen cells were cultured with Ld APCs plus QL9 pep-associated with low but significant synthesis of interleu-
kin-2 (IL-2) (Figure 1G). Paralleling the proliferative re- tide, but negligible (2%) when peptide was omitted. Sur-
prisingly, culturing 2C spleen cells with Ld APCs led tosponse, IL-2 production occurred earlier with high doses
of spleen cells (3 3 105) than with lower doses (1 3 105). appreciable (12%±15%) labeling of B (B2201) cells; this
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Figure 2. BrdU Incorporation and Surface
Markers on 2C Spleen Cells Cultured with Ld
APCs plus QL9 Peptide
(A) BrdU incorporation versus surface ex-
pression of CD8 and B220 on 2C spleen cells
(2 3 106 cells/well) cultured in a 24-well plate
for 2 days with Ld APCs (5 3 105 cells/well)
plus or minus QL9 peptide (10 mM) plus 10
mg/ml BrdU (top and middle) or pulsed with
20 mg/ml BrdU for 4 hr at day 4 (bottom)
(B, C) Expression of surface markers on 2C
spleen cells cultured at 3 3 106 cells/well in
a 24-well plate with Ld APCs plus QL9 peptide
(10 mM) for the times indicated. Using elec-
tronic gating for CD81 and B2201 cells, the
data show CD69 and CD25 expression on
CD81 cells (B) and CD69, B7-2, ICAM-1, and
B7-1 on B2201 cells (C).
applied irrespective of whether the cultures were sup- cells was very low. These data with 2C spleen cells
plemented with QL9 peptide. By contrast, BrdU labeling contrasted with culturing purified CD81 cells. Thus, par-
of B cells was almost undetectable (1%) when 2C spleen alleling the lack of a proliferative response (see Figure
cells were cultured in the absence of Ld APCs (data not 1B), culturing purified 2C CD81 cells with Ld APCs plus
shown). Drosophila APCs thus caused peptide-depen- QL9 peptide failed to up-regulate CD69 or CD25 (Figure
dent proliferation of CD81 cells but peptide-indepen- 2B).
dent proliferation of B cells. For B cells, culturing 2C spleen with Ld APCs caused
These findings applied during the early stages of cul- marked CD69 up-regulation in the absence of QL9 pep-
ture, i.e., on day 2. At this stage, with Ld APCs plus QL9 tide (Figure 2C). In addition to CD69 up-regulation, B
peptide ≈ 40% of the BrdU1 cells were B2201. However, cells cultured with Ld APCs showed early up-regulation
when BrdU was added as a 4 hr pulse late in culture, of B7-2 and increased expression of ICAM-1 (Figure 2C);
i.e., on day 4, B2201 BrdU1 cells were rare (7%) and the B7-1 expression on B cells was low at day 1 of culture
vast majority of the BrdU1 cells (90%) were CD81; in but high on day 3. Up-regulation of these B cell markers
addition, the ratio of CD81 cells to B2201 cellswas much was only minimally influenced by the addition of QL9
higher on day 4 than day 2. These findings indicated
peptide and not seen when 2C spleen cellswere cultured
that the proliferative response of B cells was transient
in the absence of Ld APCs (Figure 2C). Ld expression on
and therefore that the phase of peptide-specific prolifer-
the APCs was not important because comparable B cellation ([3H]TdR incorporation) found later in culture (see
activation was seen with uninduced Drosophila cellsFigure 1) was mediated by CD81 cells rather than B cells.
(cells not pretreated with CuSO4).To examine whether the transient proliferation of B
The above data indicate that culturing 2C spleen cellscells induced by Drosophila APCs was associated with
with Drosophila cells caused the major population of Bup-regulation of costimulatory molecules, cells were
cells in spleen (≈ 50% of spleen cells are B cells) toharvested after 1±3 days and stained for the expression
become activated and express high levels of severalof various surface markers. As expected, culturing 2C
costimulatory molecules. Therefore, in the presence ofspleen cells with Ld APCs plus QL9 peptide caused
peptide, it seemed likely that these activated B cellsstrong up-regulation of the activation markers, CD69
provided ªbystanderº costimulation for T cells, therebyand CD25 (IL-2R), on CD81 cells (Figure 2B); in the ab-
sence of peptide, expression of these markers on CD81 explaining why the CD81 cells in 2C spleen were able
Immunity
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APCs plus QL9 peptide and supplemented with Db.B7.I-
CAM Drosophila cells, i.e., cells expressing costimula-
tory molecules but lacking Ld molecules (Figure 4C).
Drosophila DNA Is Mitogenic for B Cells
The capacity of Drosophila cells to cause B cell activa-
tion was found to be mediated by a soluble factor pres-
ent in culture supernatants (Figure 5A). These superna-
tants from Drosophila cells failed to activate CD81 cells
or CD41 cells but were mitogenic for purified B cells
(T-depleted thoracic duct lymphocytes), implying that
the B cell response was T-independent (unpublished
data).
In view of the report that bacterial DNA is mitogenic
for B cells (reviewed by Pisetsky, 1996), it seemed possi-
ble that the mitogenicity of Drosophila cells was con-
trolled by DNA released from dying cells. In support of
this possibility, treatment with DNase I abolished the
mitogenic activity of the culture supernatant (Figure 5A).
To confirm this finding, we tested the activity of genomic
DNA prepared from Drosophila cells versus mouse
spleen cells. As shown in Figure 5B, adding DNA from
Figure 3. Blocking Costimulation Impairs the Proliferative Re-
Drosophila cells to normal B6 spleen cells induced asponse of 2C Spleen Cells to QL9 Peptide plus Ld APCs
significant proliferative response, which reached a peak
Proliferative responses of 2C spleen cells (1 3 105 cells/well) to QL9
on day 2 of culture; this effect was not seen with mousepeptide (10 mM) presented by Ld APCs (1 3 105 cells/well) were
DNA. As for culture supernatants, the mitogenicity ofmeasured on day 4 in the presence of various concentration of
genomic DNA from Drosophila cells was abolished byCTLA-4Ig (A) or anti-ICAM-1 MAb (B). The data show the means of
triplicate cultures. pretreatment with DNase I (Figure 5C). Collectively,
these findings indicate that the capacity of Drosophila
cells to cause B cell activation is mediated by DNA,
presumably released from dying cells.to respond to peptides presented by Drosophila APCs
In contrast with mammals, DNA of bacteria (Esche-lacking costimulatory molecules.
richia coli) and insects (Drosophila) is largely unmethyl-The notion that up-regulation of costimulatory mole-
ated (Bird, 1992). Since the mitogenicity of bacterialDNAcules onactivated B cellsprovided bystander costimula-
for mouse B cells is mediated by the unmethylated CpGtion for CD81 cells predicted that adding inhibitors of
dinucleotide motif (Krieg et al., 1995), the same couldcostimulation would block the response of 2C spleen
apply to Drosophila DNA. Evidence that the CpG motifcells to QL9 plus Ld APCs. As shown in Figures 3A and
of Drosophila DNA is unmethylated came from the find-3B, addition of either CTLA-4Ig (which binds to B7-1
ing that Drosophila DNA was susceptible to digestionand B7-2) or anti-ICAM-1 monoclonal antibody (MAb)
with HpaII restriction endonuclease (Figure 5D, lanes 1impaired the proliferative response of 2C spleen cells
and 2).to Ld APCs plus QL9 peptide. The inhibition was more
If the mitogenic effect of Drosophila DNA were medi-marked with CTLA-4Ig than with anti-ICAM-1 MAb.
ated by the unmethylated CpG motif, methylation ofTo rule out the (unlikely) possibility that QL9 peptide
Drosophila DNA would be expected to abolish the mito-
bound directly to the H-2b class I molecules on the acti-
genic effect. To examine this possibility, Drosophila DNA
vated B cells, thus enabling the B cells themselves to
was fully methylated with theCpG methylase, SssI meth-
act as APCs, we prepared class I2 2C spleen cells. These
ylase, thus inducing resistance to HpaII digestion (Figure
cells were made by reconstituting heavily irradiated 5D, lanes 4 and 5). Significantly, CpG methylation of
(1,100 cGy) B6 mice with T-depleted bone marrow cells Drosophila DNA virtually abolished the mitogenic activ-
prepared from b2-microglobulin (b2m)2 2C mice. When ity for mouse spleen cells. This is illustrated in Figure
tested at 6 weeks postreconstitution, the spleen cells 5E, inwhich graded doses of mock-treated DNA induced
in these b2m2 2C → B6 chimeras consisted largely of strong proliferation of B6 spleen cells on day 2, whereas
class I2 donor cells, including 2C CD81 cells and B cells. CpG-methylated DNA caused minimal proliferation.
After removing contaminating class I1 host cells with Similar findings occurred when responses were mea-
anti-Kb MAb plus C, the 2C chimera spleen cells were sured at other timepoints (days 1±4) (data not shown).
cultured in vitro with Ld APCs plus or minus QL9 peptide. In contrast with CpG methylation, the mitogenic activity
As shown in Figure 4A, these class I2 2C spleen cells of Drosophila DNA was not impaired by treatment with
responded well to Ld APCs plus QL9 peptide. Taq-I methylase (Figure 5F); this enzyme methylates
Similar results wereobtained by adding class I2 B cells adenosine within the TCGA motif but does not induce
to purified 2C CD81 cells. Thus, the failure of purified CpG methylation.
2C CD81 cells to respond to Ld APCs plus QL9 peptide To examine the cell types induced to proliferate by
could be overcome by adding a source of class I2 B Drosophila DNA, B6 spleencells were cultured with puri-
cells, i.e., T-depleted spleen cells prepared from normal fied Drosophila DNA for 4 days in the continuous pres-
b2m2 mice (Figure 4B). This bystander effect was also ence of 5 mg/ml BrdU (which caused weaker FACS stain-
ing than the higher dose of BrdU used in Figure 2). Asseen when purified 2C CD81 cells were cultured with Ld
Dual Function of Drosophila Cells as APCs
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Figure 4. Bystander Costimulation Provided by Class I2 B Cells and Db.B7.ICAM Drosophila Cells
(A) Proliferative response of b2m2 2C chimera spleen cells (3 3 105) to Ld APCs (3 3 105) plus QL9 peptide (10 mM). b2m2 2C → B6 chimeric
mice were made by transferring T-depleted b2m2 2C bone marrow cells to heavily irradiated B6 mice (see Experimental Procedures).
(B) Proliferative response of purified normal 2C CD81 cells (5 3 104) to Ld APCs (1 3 105) plus QL9 peptide (10 mM) supplemented with
bystander b2m2 B cells (1.5 3 105); these B cells were prepared by treating b2m2 spleen cells with anti-Thy-1 MAb plus C.
(C) Proliferative response of 2C CD81 cells (1 3 105) to Ld APCs (1 3 105) plus QL9 peptide (10 mM) supplemented with bystander Db.B7.ICAM
APCs (3 3 105).
The data show the means of triplicate cultures.
shown in Figure 6A, BrdU incorporation in the presence stabilizing Ld-expression on Ld-transfected RMA-S cells,
implying that, like QL9, the P1A.35±43 peptide hasof DNA was high for B2201 B cells but very low for CD41
very high affinity for Ld. To study CTL generation, nor-or CD81 T cells. As for spleen cells incubated with whole
mal DBA/2 spleen cells were cultured in vitro withDrosophila cells (see Figure 2), the B cells stimulated
Ld±Drosophila cells plus P1A.35±43 peptide (20 mM).by Drosophila DNA showed up-regulation of CD69 and
Lymphoid cells harvested from the cultures after 5 daysB7-2 at day 1 of culture but little change in B7-1 expres-
displayed strong CTL activity to normal P815 tumor cellssion (Figure 6B); up-regulation of B7-1 was apparent on
in vitro (without added peptide) but failed to lyse P1204,day 2±3 (data not shown).
a mutant line of P815 that lacks expression of the
P1A.35±43 peptide (Uyttenhove et al., 1983) (Figure 7B).Immunogenicity of Ld-Transfected Drosophila
When these CTL were injected into normal DBA/2 miceCells for Normal CD81 Cells
given a subcutaneous injection of P815 cells 3 daysThe immunogenicity of Drosophila APCs for 2C spleen
before, the tumor grew transiently and was eliminatedcells raised the question whether Drosophila cells could
within 2 weeks (Figure 7C). Tumor rejection was specificprovide APC function for normal (nontransgenic) T cells.
because little or no inhibition of P815 growth occurred
This question was examined by culturing normal B10.D2
after injection of CTL generated against an unrelated
(H-2d) spleen cells with Ld±Drosophila cells in the pres-
viral nucleoprotein (NP) peptide (Figure 7C) (Whitton et
ence of a 9-mer peptide, MCMV (Reddehase et al., 1989);
al., 1989).
this peptide has high binding affinity for Ld (Sykulev et al.,
1994a, 1994b). As measured by [3H]TdR incorporation, Discussion
peptide-specific responses of B10.D2 spleen cells to
MCMV were quite low and were only slightly above the This paper demonstrates that class I±transfected Dro-
background levels seen in the absence of peptide (data sophila cells play two distinct roles in stimulating naive
not shown). Despite this finding, bulk cultures of B10.D2 CD81 cells. First, because of a lack of TAP-1/TAP-2
spleen cells cultured with Ld APCs plus MCMV pep- peptide transporters, class I±transfected Drosophila
tide for 5 days contained CTL able to lyse RMA-S.Ld cells incubated with defined peptides display a very high
target cells sensitized with MCMV peptide (Figure 7A); surface density of class I±peptide complexes and thus
lysis of these target cells in the absence of peptide was promote strong TCR±CD3 cross-linking of CD81 cells.
quite low. Second, DNA released from Drosophila cells stimulates
The above findings suggested that Drosophila cells murine B cells to up-regulate the expression of costimu-
might be capable of generating CTL activity to a tumor- latory molecules, thus inducing B cells to provide by-
specific peptide. To test this possibility, we examined stander costimulation for CD81 cells. Because of these
responses to a tumor-specific peptide, P1A.35±43, from two properties of Drosophila cells, the inclusion of B
the DBA/2 (H-2d)-derived P815 mastocytoma line (van cells in the responder population allows CD81 cells to
den Eynde et al., 1991). Preliminary work established mount responses to peptides presented by Drosophila
cells expressing class I molecules alone. The dual func-that this peptide was as efficient as QL9 peptide at
Immunity
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Figure 5. Drosophila DNA Is Mitogenic for Normal Spleen Cells
(A) Proliferation of normal B6 spleen cells (5 3 105) to culture supernatant of Drosophila cells. Supernatant of Drosophila cells cultured for
3±4 days at room temperature was passed through a 0.2 mm filter before use and added to spleen cell cultures at a 1:6 dilution; DNase I
treatment was done as described in Experimental Procedures.
(B) Proliferation of B6 spleen cells (5 3 105) induced by genomic DNA prepared from Drosophila cells versus mouse spleen cells; DNA was
added at 100 mg/ml.
(C) Inhibition of the mitogenicity of Drosophila DNA by DNase I treatment; a preparation of Drosophila genomic DNA was treated with DNase
I or mock-treated as described in Experimental Procedures.
(D) The extent of CpG methylation of Drosophila DNA determined by resistance to HpaII cleavage; lanes 3 and 6 are DNA Kb markers from
Life Technologies (Gaithersburg, Maryland). DNA was run on 1% agarose gels, using either (left) fresh Drosophila DNA (about 4 mg/lane)
treated (plus, lane 1) or not treated (minus, lane 2) with HpaII, or (right) CpG-methylated (lane 5) or mock-treated (lane 4) Drosophila DNA
(about 10 mg/lane) digested with HpaII. CpG methylation of Drosophila DNA was almost complete (compare lane 5 and lane 2).
(E) Mitogenic activity of Drosophila DNA is abolished by SssI methylase (CpG → mCpG). B6 spleen cells (3 3 105 cells/well) were cultured in
the presence of a serial dilution of either CpG-methylated or mock-treated DNA for 2 days and pulsed with [3H]TdR during the last 8 hr of
culture; the data show the means of duplicate cultures.
(F) Methylation of Drosophila DNA by TaqI methylase (TCGA → TCGmA) does not impair mitogenic activity. B6 spleen cells (3 3 105 cells/
well) were cultured in the presence of TaqI-methylated DNA or mock-treated DNA (25 mg/ml). DNA methylation was carried out as described
in Experimental Procedures.
In (A, B, C, F), [3H]TdR was added during the last 8 hr; the data show the means of triplicate cultures.
tion of Drosophila cells thus circumvents the require- with DNase I and comparing Drosophila and mouse
DNA, the capacity of Drosophila cells to cause B cellment for direct expression of costimulatory molecules
on APCs. activation appeared to be mediated by DNA released
from dying cells. With regard to why Drosophila (but notBased on the effects of treating culture supernatants
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have diminished costimulatory function) can receive ef-
fective costimulation from MHC-incompatible APCs
(Mueller et al., 1989; Ding and Shevach, 1994). In these
latter studies, bystander costimulation was found to be
less effective than direct costimulation (presentation of
antigen and costimulatory molecules on the same APC)
(Liu and Janeway, 1992). In agreement with this finding,
proliferative responses of 2C spleen cells to Ld-trans-
fected Drosophila cells plus QL9 peptide were much
stronger when these APCs coexpressed costimulatory
molecules (Ld.B7.ICAM APCs). Nevertheless, with high
doses of peptide, proliferative responses stimulated by
Drosophila cells expressing Ld molecules alone were
considerable and were accompanied by strong genera-
tion of peptide-specific CTL activity.
The capacity of Drosophila cells to stimulate by-
stander APC function might have clinical potential, e.g.,
in stimulating T cells to respond to tumor-specific pep-
tides in vitro. In this respect, it is striking that Ld-trans-
fected Drosophila cells were able to induce autologous
DBA/2 spleen cells to respond to P815 mastocytoma
peptides in vitro in the absence of exogenous lympho-
kines. Moreover, the effector cells generated in the cul-
tures were capable of leading to tumor rejection in vivo.
Figure 6. Activation of Mouse B Cells by Purified Drosophila DNA Whether such tumor immunotherapy is applicable to
(A) Phenotype of spleen cell subsets incorporating BrdU after incu- human tumors is under investigation.
bation with purified Drosophila DNA. Normal B6 spleen cells (2 3
106 cells/well) were cultured in the presence of 100 mg/ml Drosophila
Experimental ProceduresDNA plus 5 mg/ml BrdU for 4 days, stained for BrdU incorporation
and the expression of cell-surface markers, and analyzed by FACS.
MiceThe data show BrdU incorporation by cells expressing B220, CD8,
2C TCR transgenic mice were originally obtained from Dr. D. Lohor CD4.
(Sha et al., 1988) and were bred and maintained at The Scripps(B) Surface markers on B2201 B cells activated by purified Drosoph-
Research Institute (TSRI). C57BL/6J (B6), B10.D2/NsnJ (B10.D2),ila DNA. 2C spleen cells (3 3 106/well) were cultured with purified
DBA/2J and b2m2/2 mice were bred at TSRI.Drosophila DNA (100 mg/ml) or in medium alone for 1 day and then
stained for expression of B220 versus the markers shown, followed
Antibodies and Cell Linesby FACS analysis.
The following MAbs were used: 3.168 (anti-CD8) (Sarmiento et al.,
1980); RL172 (anti-CD4) (Ceredig et al., 1985); J11d (anti-heat stable
antigen) (Bruce et al., 1981); 28-16-8s (anti-I-Ab) (Ozato and Sachs,mouse) DNA is mitogenic for B cells, it is of interest
1981); 28-8-6s (anti-H-2d,b) (Ozato and Sachs, 1981); J1j.10 (anti-that bacterial DNA has a similar property (reviewed by
Thy-1.2) (Bruce et al., 1981). The RMA-S.Ld cell line and 1B2, the
Pisetsky, 1996). As for bacterial DNA (Krieg et al., 1995), clonotypic MAb for 2C TCR, were provided by Dr. H. Eisen (Massa-
we show here that CpG methylation abolished the mito- chusetts Institute of Technology, Cambridge, Massachusetts)
genic activity of Drosophila DNA, implying that B cell (Kranz et al., 1984). A cell line producing CTLA-4Ig fusion protein
was a gift of Dr. P. Lane (Basel Institute for Immunology, Basel,activation is mediated by unmethylated CpG motifs. The
Switzerland) (Lane et al., 1993). Conjugated-antibodies (phycoer-mitogenic effects of bacterial and insect DNA thus ap-
ythrin [PE]±anti-CD8, PE±anti-B220, fluorescein isothiocyanatepear to be quite similar. Why B cells undergo activation
[FITC]±anti-B7-1, FITC±anti-B7-2, FITC±anti-ICAM-1, FITC±anti-
in response to unmethylated CpG motifs, however, is CD69, FITC±anti-CD25) used in cell surface staining for FACS analy-
still unclear. sis and anti-ICAM-1 for antibody-blocking experiments were pur-
B cell activation by Drosophila cells or Drosophila chased from PharMingen (San Diego, California). FITC±anti-BrdU
MAb was purchased from Becton Dickinson and Company (Moun-DNA was prominent early in culture but was inconspicu-
tain View, California).ous after day 3. Thus, for the response of unseparated
2C spleen cells to Ld APCs plus peptide, the brevity of the
PeptidesB cell proliferative response meant that the proliferation
Peptides were synthesized onan Applied Bio-systems431 A synthe-
seen later in culture was largely restricted to peptide- sizer. All peptides were purified with C18 reverse-phase high perfor-
specific T cells. This was confirmed by the finding that, mance liquid chromatography. The concentration of peptides was
after a BrdU pulse late in culture, the vast majority of determined based on their molecular weight.
the BrdU1 cells were CD81 T cells.
The possibility that the B cells activated by Drosophila Media
As described previously (Sprent and Schaefer, 1985), Hank's bal-cells acted as direct APCs, i.e., by presenting peptides
anced salt solution supplemented with 2.5% g globulin±free horsebound to B cell MHC molecules, was ruled out by the
serum (GIBCO Laboratories, Santa Clara, California) was used forfinding that high responses occurred with class I2 2C
preparation of single cell suspensions. For proliferation assays,
spleen cells. This finding is in accord with other exam- RPMI 1640 was supplemented with 10% fetal calf serum (Irvine
ples of bystander costimulation, e.g., where T cell clones Scientific, Santa Ana, California), 5% NCTC 109, 2 mM glutamine,
5 3 1025 M 2-mercaptoethanol, and antibiotics.responding to antigen presented by fixed APCs (which
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Figure 7. Effector Function of Normal H-2d Spleen Cells Cultured with Ld APCs and MCMV or P1A.35±43 Peptides
(A) Generation of MCMV peptide-specific CTL from normal B10.D2 spleen cells. Unseparated B10.D2 spleen cells (3 3 106 cell/well) were
cultured in a 24-well plate with Ld APCs (1 3 106 cells/well) plus 20 mM MCMV peptide for 5 days. Effector cells were then harvested and
tested for their ability to lyse 51Cr-labeled RMA-S.Ld target cells in the presence or absence of the sensitizing MCMV peptide.
(B) Generation of tumor-specific CTL from normal DBA/2 spleen cells. Bulk populations of unseparated DBA/2 spleen cells (3 3 107) were
cultured with Ld APCs (3 3 106) plus P815-derived P1A.35±43 peptide (20 mM) in 20 ml volume for 5 days and then tested for CTL activity on
51Cr-labeled P815 cells or P1204 cells.
(C) Inhibition of P815 tumor growth in DBA/2 mice. DBA/2 mice were injected subcutaneously with 5 3 105 P815 cells and then, 3 days later,
injected intravenously with 2 3 107 DBA/2 CTL sensitized in vitro against either P1A.35±43 or LCMV NP peptide; control groups of mice were
injected with PBS. The data show the mean tumor size in 10 mice/group; the data are representative of three separate experiments.
Cell Purification Generation of CTL
2C CTL were generated by culturing 3 3 106 2C spleen cells and2C CD81 cells were purified as described previously (Cai and Sprent,
1994) from pooled cervical, axillary, inguinal, and mesenteric lymph 3 3 106 Ld APCs plus QL9 peptide (10 mM) in a 24-well plate for 4
days. CTL against MCMV peptide were generated by culturing 3 3nodes of 2C TCR transgenic mice on a C57BL/6 (B6) background.
Lymph node cells were first treated with a cocktail of MAbs (anti- 106 B10.D2 spleen cells and 1 3 106 Ld APCs plus MCMV (20 mM)
in a 24-well plate for 5 days. Tumor-specific CTL were generatedCD4, anti-heat stable antigen, anti-I-Ab) plus C for 45 min at 378C
to remove CD41 cells and B cells. CD81 cells were then purified by by culturing 3 3 107 DBA/2 spleen cells with 3 3 106 Ld APCs plus
P1A.35±43 peptide (van den Eynde et al., 1991) orLCMV NP 118±126positive panning on plates coated with anti-CD8 MAbs; >95% of the
CD81 cells obtained were clonotype positive (1B21) and displayed a peptide (Whitton et al., 1989) (20 mM) in vitro. Cells were cultured
in 20 ml volumes in flasks with standard MLR medium and withoutnaive (CD44lo) phenotype. Depletion of B or T cells from spleen
cell suspensions was accomplished by incubating spleen cells with added lymphokines. Effector cells were harvested after 5 days and
tested for their capacity to lyse tumor targets in vitro or induceeither J11d (anti-heat stable antigen) or anti-Thy-1.2 MAb plus C
for 45 min at 378C. tumor rejection in vivo. For tumor growth analysis, DBA/2 mice were
injected subcutaneously with 5 3 105 P815 cells and then, 3 days
later, injected intravenously with 2 3 107 DBA/2 CTL sensitized inPreparation of Drosophila Cell APCs
Generation of stable Drosophila cell lines expressing mouse b2m, vitro against either P1A.35±43 or LCMV NP peptide. Tumor growth
in vivo was measured every second day.mouse MHC class I molecules (Ld, Db, or Kb), and B7-1 and ICAM-1
molecules was carried out as described elsewhere (Jackson et al.,
1992; Z. C. et al., submitted). The genes used for transfection had a CTL Assay
To prepare target cells, Ld-transfected RMA-S cells were labeledmetallathionein promoter, and expression of cell surface molecules
was induced by addition of CuSO4 to a final concentration of 1 mM. with 51Cr (100 mCi/1 3 106 cells) and sensitized with peptide (10 or
20 mM) at 378C for 90 min, and then washed thoroughly. To measureFor use as APCs, cells incubated with CuSO4 for 24 hr were washed
three times in Hank's balanced salt solution plus 2.5% horse serum CTL activity, varying numbers of cells were cultured with 1 3 104
51Cr-labeled and peptide-sensitized targets in the presence of theand incubated for 2 hr in standard mixed lymphocyte reaction (MLR)
medium in the presence or absence of peptides. sensitizing peptide at 378C for 4 hr. Supernatants were harvested
to measure 51Cr release. All the data refer to the mean of duplicate
cultures; SD were within 5%±15% of the mean. Percent-specificProliferation Assay
After induction and incubation with peptides, Drosophila cells were lysis was calculated as described elsewhere (Cai and Sprent, 1994).
plated at 0.5±1.5 3 106 cells/ml without washing with either unsepa-
rated spleen cells (0.5±1.5 3 106 cells/ml) or purified 2C CD81 cells Staining of Cell Surface Molecules
Cultured cells were first depleted of dead cells and cell debris by(1.25±5 3 105 cells/ml) in 96-well or 24-well plates at 378C plus 5%
CO2. After incubation for the indicated time, cultures from 96-well Ficoll-gradient centrifugation (Sigma). After washing, cells were
stained with either PE-conjugated anti-B220 or PE-conjugated anti-plates were pulsed with 1 mCi [3H]TdR 8 hr before harvest. Cultures
from 24-wellplates were harvested at the indicated times for staining CD8 MAbs and FITC-conjugated anti-CD69, anti-CD25, anti-B7-1,
anti-B7-2, or anti-ICAM-1 MAbs. Propidium iodide was also includedof cell surface molecules or analyzed for CTL activity. IL-2 produc-
tion in the cultures was tested by adding culture supernatants to at a concentration of 0.5 mg/ml. Live cells (propidium iodide-nega-
tive) were acquired and analyzed on a FACScan flow cytometerthe IL-2-dependent CTLL line and then measuring proliferation of
CTLL with [3H]TdR (Cai and Sprent, 1994). (Becton Dickinson and Company).
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Staining for BrdU Incorporation the United States Public Health Service. This is publication number
9546-IMM from the Scripps Research Institute.2C spleen cells (2 3 106 cells/well) and Ld-transfected Drosophila
cells (5 3 105 cells/well) were cocultured in 2 ml in a 24-well plate
Received , 1996; revised , 1996.for 48 hr with or without QL9 peptide in the presence of 10 mg/ml
BrdU (Sigma Chemical Company) or pulsed with 20 mg/ml BrdU for
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